A UM investigation that began in late May 2011 eventually led to the discovery that Manuel Gerardo Pacheco, a pharmacy technician employed by UM, had been removing drugs from the cancer center’s pharmacy since November 2010 and selling them to someone outside the organization.
Investigators found Mr. Pacheco had stolen the following medications:
• Neulasta, used to reduce the risk of infection.
• Aloxi, used to treat nausea in chemotherapy patients.
• Avastin and Oxaliplatin, used to treat colon cancer.
• Rituxan, used for non-Hodgkin’s lymphoma.
• Aranesp, for chronic kidney failure.
• Velcade, used for bone-marrow cancer.
Navigant Economics, a company hired by UM for the case, estimated Mr. Pacheco stole a total of at least $14 million over the three years.
Mr. Pacheco was charged with four counts of grand theft, two counts of trafficking in contraband prescription drugs and one count of dealing in stolen property. He has pleaded not guilty, according to the report.
More Articles on University of Miami:
University of Miami Hospital Reaches Labor Deal With Union
University of Miami Medical School Layoffs Prompted by Failed Strategies, Critics Say
Jackson Health Board Votes to Escrow Payments to University of Miami
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
